defi cient J ␣ 18 ؊ / ؊ mice failed to develop IL-25 -dependent AHR. Cell transfer of IL-17RB + but not IL-17RB ؊ NKT cells into J ␣ 18 ؊ / ؊ mice also successfully reconstituted AHR induction. These results strongly suggest that IL-17RB + CD4 + NKT cells play a crucial role in the pathogenesis of asthma.
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Airway hypersensitive reaction (AHR) ( 1 ) is known to be associated with Th2 cytokinesincluding IL-4, IL-5, and IL-13 -regulating effector functions ( 2 ) . Indeed, overexpression of these Th2 cytokines results in the development of AHR ( 3 ) . However, eff orts to ameliorate experimental asthma with antibodies against Th2 cytokines have generally proven unsuccessful. Among these, only IL-13 seems to be a key cytokine responsible for goblet cell hyperplasia, airway remodeling, and AHR ( 4 ), because inhibition of IL-13 activity, but not that of other Th2 cytokines, by a blocking antibody suppresses both AHR and airway infl ammation.
IL-25 (also known as IL-17E), a member of the structurally related IL-17 cytokine family ( 5 -7 ) , has recently been reported to be produced by activated Th2 cells ( 5 ) and mast cells ( 8 ) , resulting in enhancement of AHR ( 9, 10 ) . Administration of a blocking antibody against IL-25 ( 11 ) or IL-25 -defi cient mice ( 12 ) eliminates Th2 responses. Conversely, systemic expression of either human ( 7 ) or mouse ( 11 ) IL-25, or administration of recombinant IL-25 ( 5 ) , induces Th2-type immune responses, including increased serum IgE levels, blood eosinophilia, and pathological changes in the lung and other tissues. These fi ndings clearly demonstrate a pivotal role of IL-25 as a mediator of Th2 responses, suggesting that IL-25 lies upstream of the classical Th2 cytokine responses ( 5, 11 ) .
NKT cells characterized by the expression of an invariant antigen receptor encoded by V ␣ 14J ␣ 18 in mice or V ␣ 24J ␣ 18 in humans are also involved in the development of asthma, because NKT cell -defi cient J ␣ 18 Ϫ / Ϫ mice fail to develop antigen-induced AHR ( 13 ) . Th2 cells are not always essential for NKT cell -mediated AHR development, because activation of NKT cells induces AHR in the absence of CD4 + T ( Fig. S1 , available at http://www.jem.org/cgi/content/full/ jem.20080698/DC1) by immunization with a recombinant IL-17RB -Ig fusion protein (Fig. S2 ). We fi rst investigated IL-17RB + cells in the spleen by mouse IL-17RB mAb to confi rm the previous fi ndings that IL-17RB expression is detected on a fraction of non -B/non -T (NBNT), c-kit + , Fc RI Ϫ cells in the mesenteric lymph node (Fig. S3 ), which has identifi ed as IL-4 -, IL-5 -, IL-13 -producing cells in response to IL-25 ( 12 ) . NKT cells were distinct from the NBNT c-kit + cells based on the expression of c-kit Ϫ , Fc RI Ϫ , V ␣ 14-J ␣ 18 + transcripts detected by RT-PCR ( Fig. S4 ). Moreover, IL-17RB was preferentially expressed on a fraction of ␣ -galactosylceramide ( ␣ -GalCer)/CD1d dimer + NKT cells but not on other cell types, including NBNT c-kit + cells, CD4 + T cells, CD8 + T cells, ␥ ␦ + T cells, CD19 + B cells, CD11c + DCs, DX5 + NK cells, or noninvariant NKT cells in the spleen ( Fig. 1 A ) .
The preferential expression of IL-17RB in a fraction of NKT cells raises a question about the phenotypic and functional cells in MHC class II -defi cient mice ( 14 ) . These fi ndings suggest that NKT cells are directly involved in the development of AHR independent of Th2 responses in some conditions. In this report, we investigated the role of IL-25 in NKT celldependent AHR induction in mouse models and found that IL-17RB, a receptor for IL-25, was selectively expressed on a fraction of mouse NKT cells, which preferentially produced IL-13 and induced the development of AHR upon stimulation with IL-25.
RESULTS AND DISCUSSION
We fi rst investigated the role of IL-25 in the development of AHR in relation to NKT cells because of previous fi ndings that IL-25 induces Th2-biased responses ( 5 -7 ) . The receptor for IL-25, termed IL-17RB or EVI27/IL-17BR, was originally found to bind IL-17B ( 15 ) . Interestingly, however, the receptor binds IL-25 with higher affi nity than IL-17B. Therefore, this receptor is now termed IL-17RB/IL-25R ( 15 ) . To identify mouse IL-17RB + cells, we generated specifi c mAbs Table S1 (available at http://www.jem.org/cgi/content/full/jem.20080698/DC1) and is depicted as the number of transcripts per one copy of the housekeeping gene HPRT. One representative out of three experiments is shown (means ± SEM). production ( 21 ) and for IL-21 production ( 22 ) , in NKT cell activation. Under these conditions, IL-25 -activated IL-17RB + NKT cells mainly produced IL-13, along with modest production of IL-4, but barely produced IFN-␥ ( Fig. 2 B ) . Moreover, IL-17RB + NKT cells produced Th2 chemokines such as thymus and activation-regulated chemokine/CCL17, macrophage-derived chemokine/CCL22, and C10/CCL6 as well as eosinophil chemotactic factor -L (ECF-L) upon stimulation with IL-25 ( Fig. 2 C ) . These results indicate that IL-25 triggers IL-17RB + NKT cells to preferentially produce the IL-13, Th2 chemokines, and ECF-L important for recruitment of eosinophils.
Recently, other IL-17 family members, IL-17A or IL-17F, have been shown to be involved in chronic infl ammatory and allergic lung diseases ( 23, 24 ) . The expression levels of IL-17A mRNA in IL-17RB + NKT cells were slightly elevated after treatment with IL-25 ( Fig. 2 C ) . However, levels of IL-17A and ROR ␥ t mRNA in IL-17RB + NKT cells were lower than those in DN NKT cells ( Fig. 1 H ) . Because high expression of ROR ␥ t is one of the markers for Th17 cells, low expression of ROR ␥ t in IL-17RB + NKT cells ( Fig. 1 H ) indicates that IL-17RB + NKT cells are distinct from IL-17 -producing NKT cells. In addition, even though NK1.1-negative NKT cells represent IL-17 -producing cells in C57BL/6 mice ( 25, 26 ) , it characteristics of these cells. Based on our current understanding, NKT cells are divided into two populations based on CD4/ CD8 expression: a CD4 + and a CD4 Ϫ CD8 Ϫ double-negative (DN) population ( 16 ) . Using an IL-17RB mAb, we found that one third of the CD4 + but none of the DN NKT cells expressed IL-17RB, indicating the existence of three subpopulations: DN, IL-17RB Ϫ CD4 + , and IL-17RB + CD4 + NKT cells ( Fig. 1 B ) . Moreover, the majority of IL-17RB + NKT cells were dimly positive for CD69 and CD122 compared with brightly positive DN NKT and IL-17RB Ϫ CD4 + NKT cells ( Fig. 1 C ) . The expression level of CD62L by IL-17RB + NKT cells was low, comparable to that on IL-17RB Ϫ CD4 + NKT cells and similar to that of conventional memory T cells, whereas it was quite high on DN NKT cells. In addition, IL-17RB + NKT cells (3%), like IL-17RB Ϫ CD4 + NKT cells (11%), barely expressed an NK receptor, NKG2D, which was highly expressed on the majority ( > 60%) of DN NKT cells, suggesting their cytotoxic nature ( 17 ) .
To investigate cytokine and chemokine gene expression profi les on IL-17RB + NKT cells, we performed quantitative real-time PCR using primer sets as shown in Table S1 (available at http://www.jem.org/cgi/content/full/jem.20080698/DC1). The expression of the Th2 chemokine receptor CCR4 was several times higher on IL-17RB + NKT cells than on the other subsets, whereas no signifi cant diff erences were found in CXCR6 expression ( Fig. 1 D ) , which is important for NKT cell migration ( 18 ) . The results are consistent with the previous fi ndings that NKT cells require CCR4 to localize to the airways and to induce AHR ( 19 ) .
Concerning cytokine production of IL-17RB + NKT cells, it is reported that NKT cells produce both Th1 and Th2 cytokines at the same time upon stimulation with their ligand, ␣ -GalCer ( 20 ) . Surprisingly, IL-17RB + NKT cells expressed lower levels of Th1-related transcripts, such as IFN-␥ , T-bet , Stat4 , IL-18R ␤ , and IL-12R ␤ 2 ( Fig. 1 E ) , whereas higher levels of the Th2-related transcript IL-4 were detected ( Fig. 1 F ) . In contrast, transcripts for cytotoxic eff ector molecules, such as Granzyme , Perforin , and killer receptors ( KIRa1 , KIRc1 , KIRd1 , and KIRg1) , were expressed mainly in DN NKT cells ( Fig. 1 G ) , supporting the previous fi ndings that DN NKT but not CD4 + NKT cells predominantly mediate antitumor immunity ( 19 ) and also that NKG2D was predominantly expressed on DN NKT cells, as shown in Fig. 1 C . The expression levels of IL-17A and ROR ␥ t transcripts in IL-17RB + NKT cells, which are high in Th17 cells, were lower than those in DN NKT cells ( Fig. 1 H ) . These results on surface phenotypes and mRNA expression profi les clearly indicate that IL-17RB + NKT cells are Th2-type NKT cells and are distinct from other NKT cells, such as DN NKT cells or IL-17 -producing NKT cells.
Next, we analyzed the function of IL-17RB + NKT cells in response to IL-25 in vitro. IL-17RB + NKT but not CD4 + IL-17RB Ϫ nor DN NKT cells responded to IL-25 in a dosedependent manner only in the presence of APCs ( Fig. 2 A ) , which is similar to previous fi ndings on the requirement of two signals, such as IL-12 and CD1d on APCs for IFN-␥ .org/cgi/content/full/jem.20080698/DC1). We also found that IL-17RB + NKT cells were detected more in the lung and spleen than the thymus but were almost undetectable in the liver. Although the number of NKT cells in the lung was one tenth of that in the spleen or the thymus, IL-17RB + NKT cells make up a higher proportion in the total NKT cells in the lung ( Fig. 3 A ) . Similar to the splenic NKT cells shown in Fig. 1 A , the selective expression of IL-17RB on NKT cells was also detected in the lung, whereas conventional CD4 + T, ␥ ␦ + T, c-kit + NBNT, and noninvariant NKT cells in the lung were negative or barely detectable ( Fig. 3 B ) .
To determine whether IL-17RB + NKT cells are required for IL-25 in the development of AHR, WT mice were has also been reported that IL-17 -producing NKT cells are not restricted to a particular NKT cell subset ( 27 ) . Another report has also revealed that ozone-but not allergen-induced AHR requires IL-17A produced from both NKT and T cells ( 28 ) . These results suggest that IL-17RB + NKT cells described in this report are not equivalent to IL-17A -producing NKT cells reported by others.
We further examined whether the frequency of IL-17RB + NKT cells diff ers among mouse strains because allergic responses are strain dependent. Intriguingly, IL-17RB + NKT cells were fairly abundant in Th2-prone BALB/c and DBA2/ cr mice but were barely detectable in Th1-prone C57BL/6 and C3H/HeN mice (Fig. S5 , available at http://www.jem 
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by OVA plus IL-25, indicating that IL-17RB + NKT cells in the lung are functionally equivalent to those in the spleen. In addition, when equal numbers of cells were transferred, the severity of AHR induced by enriched IL-17RB + NKT cells was almost three times higher than the total spleen NKT cells ( Fig. 4 D ) , consistent with the ratio of IL-17RB + NKT cells ( Fig. 1 B ) . This indicates that the severity of AHR depends on the cell numbers of IL-17RB + NKT cells transferred ( Fig. 4 D ) and, thus, that IL-17RB + NKT cells contribute to the development of IL-25 -dependent AHR.
immunized with a suboptimal dose of OVA/alum twice and were subsequently treated with PBS before a single intranasal OVA challenge (see Materials and methods). Under these conditions, the mice failed to develop AHR. When the mice were subsequently treated with IL-25 instead of PBS, they developed AHR ( Fig. 3 C ) . In contrast, even after treatment with IL-25, NKT cell -defi cient J ␣ 18 Ϫ / Ϫ mice failed to develop signifi cant AHR, comparable to that seen in the PBStreated control mice ( Fig. 3 C ) . Unlike WT mice, J ␣ 18 Ϫ / Ϫ mice treated with IL-25 signifi cantly reduced numbers of airway macrophages, eosinophils, neutrophils, and lymphocytes in the lung ( Fig. 3 D ) .
Hematoxylin and eosin staining of the lung tissue of IL-25 -treated WT mice revealed that the levels of infi ltration of infl ammatory mononuclear cells into the peribronchiolar region were higher in WT mice with severe tissue destruction compared with those in J ␣ 18 Ϫ / Ϫ mice. No infl ammatory cell infi ltration was detected in untreated WT or J ␣ 18 Ϫ / Ϫ mice ( Fig. 3 E ) . By periodic acid Schiff staining, mucus-producing cells were abundant only in IL-25 -treated WT but not J ␣ 18 Ϫ / Ϫ mice ( Fig. 3 F ) . To further investigate the eff ects on allergic responses mediated by IL-17RB + NKT cells, we examined cytokine production in the bronchoalveolar lavage (BAL) fl uid of IL-25 -treated WT or J ␣ 18 Ϫ / Ϫ mice and controls. The production of IL-5 and IL-13, which plays a crucial role in the recruitment of eosinophils and Th2 cells, respectively, were detected only in IL-25 -treated WT mice ( Fig. 3 G ) . Even though IL-17RB + NKT cells did not produce IL-5 upon IL-25 stimulation ( Fig. 2 B ) , they produced ECF-L ( Fig. 2 C ) , which is important for the recruitment of eosinophils producing IL-5. These results strongly suggest that IL-25 acts directly on NKT cells and induces AHR.
We then investigated whether IL-17RB + NKT cells are involved in the development of IL-25 -dependent AHR, and we depleted IL-17RB + cells with 3H8 IL-17RB mAb. Among the NKT cell populations, the majority of IL-17RB + NKT cells were ␣ -GalCer/CD1d dimer hi TCR ␤ hi , indicating that the expression level of TCR ␣ and TCR ␤ on IL-17RB + NKT cells was higher than that on other IL-17RB Ϫ NKT cells ( Fig.  4 A ) . IL-17RB + NKT depletion persisted for at least 5 d after 3H8 IL-17RB mAb injection ( Fig. 4 B ) , whereas no eff ects were detected on other cell types, such as CD4 + T, ␥ ␦ + T, and NBNT c-kit + cells (Fig. S6 , available at http://www.jem .org/cgi/content/full/jem.20080698/DC1). As expected, treatment of 3H8 IL-17RB mAb signifi cantly induced suppression of AHR ( Fig. 4 C ) , which was tightly correlated with the reduction of the number of IL-17RB + NKT cells ( Fig. 4 B ) . Administration of an isotype-matched control mAb did not suppress AHR ( Fig. 4 C ) , and the number of IL-17RB + NKT cells remained unchanged ( Fig. 4 B ) .
To confi rm the fi ndings that IL-17RB + NKT cells are essential for the development of IL-25 -dependent AHR, we transferred enriched splenic IL-17RB + NKT cells into J ␣ 18 Ϫ / Ϫ mice and tested their ability to develop IL-25 -dependent AHR ( Fig. 4 D ) . The cell transfer of IL-17RB + NKT cells, but not IL-17RB Ϫ NKT cells nor PBS alone, restored AHR induced ␣ -GalCer/CD1d dimer hi TCR ␤ hi NKT cells and ␣ -GalCer/CD1d dimer int TCR ␤ int NKT cells in the spleen from BALB/c mice were gated, and IL-17RB expression was analyzed using F(ab Ј ) 2 IL-17RB mAb B5F6. IL-17RB was preferentially expressed in ␣ -GalCer/CD1d dimer hi TCR ␤ hi NKT cells ( n = 3). (B) FACS profi les of NKT cells in mice treated with IL-17RB mAb. ␣ -GalCer/CD1d dimer + TCR ␤ + NKT cells in the spleen from BALB/c mice at the indicated days after injection of 3H8 IL-17RB mAb or control rat IgG2a (1 mg/mouse) were gated and analyzed by FACS. Depletion of IL-17RB + NKT cells persisted for at least 5 d after 3H8 injection because of the absence of ␣ -GalCer/CD1d dimer hi TCR ␤ hi NKT cells in A ( n = 2). Percentages are shown. (C) Development of AHR in mice treated with IL-17RB mAb. The detailed method for development of OVA/IL-25 -induced AHR is described in Materials and methods. In brief, OVA/alum-sensitized mice were injected with 3H8 IL-17RB mAb or rat IgG2a (1 mg/mouse) 24 h before 2 μ g IL-25 or PBS treatment and were challenged with OVA after 24 h, and R L was determined after 48 h. The group of rat IgG2atreated WT mice was compared with three other groups. Results are expressed as means ± SEM. The results represent one out of three experiments with fi ve mice in each group. *, P < 0.05; and **, P < 0. Quantitative real-time PCR. The PCR was performed with the Platinum SYBR Green qPCR SuperMix-UGD kit with ROX (Invitrogen) according to the protocol provided. A sequence detection system (ABI PRISM 7900HT; Applied Biosystems) was used for quantitative real-time PCR according to the manufacturer ' s instructions. To ensure the specifi city of the amplifi cation products, a melting curve analysis was performed. Results were normalized using the internal control gene HPRT. Sequences of PCR primers (Table S1 ) were designed with Primer Express software (Applied Biosystems) for optimal product length, germinal center content, and Tm value. Online supplemental material. Fig. S1 shows generation of mouse IL-17RB -specifi c mAbs. Fig. S2 shows expression and purifi cation of mouse IL-17RB -Ig fusion protein. Fig. S3 shows FACS profi les of cells stained with mouse IL-17RB -specifi c mAbs. Fig. S4 shows RT-PCR analysis on c-kit + NBNT cells and NKT cell subsets. Fig. S5 provides IL-17RB + NKT cells in diff erent mouse strains. Fig. S6 shows FACS analysis on CD4 + T, ␥ ␦ + T, and c-kit + NBNT cells in mice treated with anti -IL-17RB mAb. Table S1 lists primers used for quantitative real-time PCR analysis. Online supplemental material is available at http://www.jem.org/cgi/content/ full/jem.20080698/DC1. Although we have not identifi ed the cells producing IL-25 in the present report, it is detected in lung biopsy samples from patients with asthma ( 29 ) . In addition, IL-25 has been reported to induce infl ammatory cytokine and chemokine production by human lung fi broblasts, and components of extracellular matrix by airway smooth muscle cells ( 29 ) . These reports have also suggested that IL-25 plays a role in human asthma ( 29 ) . Our fi ndings clearly revealed IL-17RB + NKT cells as target cells of IL-25 in the development of AHR or asthma. The effi cacy with which IL-17RB antibodies prevent AHR and reduce Th2-cytokine -induced infl ammation in vivo suggests that IL-17RB is an ideal therapeutic target for asthma.
MATERIALS AND METHODS
Mice. BALB/c mice were purchased from Charles River Laboratories or Clea Japan, Inc. J ␣ 18-defi cient mice were generated as previously described ( 30 ) and were backcrossed > 10 times to BALB/c mice. Mice were kept under specifi c pathogen-free conditions and were used at 8 -16 wk of age. All experiments were in accordance with protocols approved by the RIKEN Animal Care and Use Committee.
Generation of mouse IL-17RB
-specifi c mAbs. The IL-17RB -Ig fusion gene was created by fusing the cDNA of the extracellular domain of mouse IL-17RB in frame to the CH2/CH3 domains of human IgG1 in the pIRES2-EGFP expression vector (Clontech Laboratories, Inc.). IL-17RB -Ig was purifi ed from the culture supernatants of transfected HEK293 cells using a protein A -sepharose column (GE Healthcare; Fig. S2 ). Mouse IL-17RB mAbs were produced by immunizing Wister rats with IL-17RB -Ig. After initial screening by ELISA on IL-17RB -Ig fusion protein, 100 hybridoma clones were further characterized by fl ow cytometry on IL-17RB transfectants (Fig. S1 ).
OVA/IL-25 -induced AHR model. The original protocol for induction of AHR by OVA sensitization (100 μ g three times) and challenge (100 μ g OVA/alum three times), as previously described ( 16 ) , was modifi ed in the present study. In our modifi ed method, mice were intraperitoneally immunized with a suboptimal dose of OVA/alum twice and were subsequently challenged once with intranasal OVA at the same time points as described. In this model, BALB/c mice failed to induce development of AHR, cell infi ltration, and histological changes in the lung without IL-25 but induced AHR with intravenous injection of IL-25 ( Fig. 3 ) . In brief, mice were intraperitoneally immunized with 50 μ g/2 mg OVA/alum twice at a 1-wk interval. 7 d later, mice were treated intravenously with 2 μ g/200 μ l IL-25 or 200 μ l of control PBS at 2 d before intranasal challenge with 50 μ g OVA. 24 h later, AHR responses were measured. For transfer of IL-17RB + , IL-17RB Ϫ NKT, or total NKT cells, cells were sorted by a FACSAria (BD). Sorted cells or PBS alone were intravenously injected 1 d before IL-25 treatment ( Fig. 4 D ) . For depletion of IL-17RB + cells, 1 mg 3H8 IL-17RB mAb was intraperitoneally injected 5 d before AHR measurement ( Fig. 4 C ) .
Measurement of airway responsiveness. Airway function was measured for changes in lung resistance (R L ) and dynamic compliance in response to increasing doses of inhaled methacholine (1.25, 2.5, 5, 10, and 20 mg/ml) by using an invasive fl exiVent (SCIREQ Scientifi c Respiratory Equipment Inc.).
Lymphocyte isolation and analysis of BAL fl uid. After measurement of AHR and death, the lung of the mouse trachea canulated was lavaged twice with 1 ml PBS ( ‫ف‬ 10-fold PBS dilution), and the BAL fl uid was pooled as previously described ( 13 ) . Spleen, blood, and lung lymphocytes were isolated as described previously ( 31 ) .
Cytokine measurement. BAL fl uid and culture supernatants were collected and analyzed by cytometric bead array (BD) according to the manufacturer ' s protocol.
